Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Senicapoc in Sickle Cell Anemia
NCT00040677Phase 2Completed
- Sponsor
- Icagen
- Start
- Feb 2002
- Primary completion
- Nov 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of senicapoc in sickle cell anemia (SCA), sponsored by Icagen. Started Feb 2002; status: completed.
02
Drugs
senicapoc
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT00040677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00040677.